Altogether, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, toxicity profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities
And in 2022, I started Mounjaro (tirzepatide), which is FDA-approved for type 2 diabetes but used off-label for weight loss
WARNING: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm
Many ask around to compare what others are paying and explore ways to reduce out-of-pocket expenses while maintaining access to treatment
But this isnt just about the number on the scale, its about where the weight goes
Differential Effects of Glucagon-Like Peptide-1 Receptor Agonists on Heart Rate